Clinical Trial Update: Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a fluticasone-vilanterol combination dosed once daily in adults with mild asthma, covering Phase 2 and Phase 3 results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone-Vilanterol (Fluticasone furoate/Vilanterol)

Snippet

Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED